LSN Life Sciences Institute Inc.

LIFE SCIENCES INSTITUTE INC. (the "Corporation or Life Sciences") (TSX
VENTURE:LSN), is pleased to announce that further to its announcement of Jan 15,
2010 it is now offering a total of 6,666,666 common shares to be issued on a
"flow-through" basis (each a "Flow-Through Share") at a price of $0.12 per
Flow-Through Share (the "FT Offering"). The Corporation may pay finders a fee of
up to an 8.00% of the gross proceeds of the FT Offering. Hold periods will apply
to the securities issued under this FT Offering in accordance with applicable
securities laws. This Offering is subject to the approval of the TSX Venture
Exchange.


Further the Corporation is please to announce that on March 22, 2010 it closed
the first tranche of the FT Offering through the issuance of 1,250,000
Flow-Through Shares at a price of $0.12 per Flow-Through Share for aggregate
gross proceeds of $150,000. No commissions or finder's fee were paid relative to
this offering. Hold periods will apply to the securities issued under this
offering in accordance with applicable securities laws.


In addition, further to its announcement of November 2, 2009 the Corporation is
please to announce that it has closed an offering (the "Offering") of 10,181,260
units (each a "Unit") at a price of $0.05 per Unit for aggregate gross proceeds
of $509,063. Each Unit consisted of one common share of Life Sciences (each a
"Life Sciences Share") and one transferable warrant (each a "Warrant"). Each
Warrant entitles the holder thereof to acquire one additional Life Sciences
Share at a price of $0.067 per share, for a period of 24 months from the date of
the closing of the Offering. The securities offered pursuant to the Offering
shall be subject to a four month hold period from the time of the completion of
the Corporation's Change of Business ("COB") as announced on November 2, 2009,
pursuant to the Seed Share Resale restrictions under Policy 5.4 of the TSXV
Corporate Finance Manual. 


The Corporation intends to use the proceeds relative to Offering to initially
cover certain general administrative expenses and certain expenses relative to
maintaining the certain assets. In addition, the Corporation intends to use the
FT Offering proceeds to run a 3D/3C seismic survey over its land holdings in
Saskatchewan. Following analysis of the survey, three exploration wells are
forecast to be drilled to evaluate the oil target formations and three
additional shallow wells to evaluate the shallow gas targets. Depending on
results of the exploratory work, up to 20 oil wells and 20 gas wells may be
drilled to develop these prospects.


Updated information relative to the COB will be included in a subsequent News
Release of the Corporation.


Further to its November 2, 2009 News Release the Life Sciences Shares are
currently suspended from trading. The Exchange has informed the Corporation that
reinstatement to trading of the Life Sciences Shares will not occur until such
time as all of the outstanding Exchange requirements have been satisfied. To
date, the Corporation must still complete its submissions to satisfy these
requirements. Until such time as the Compliance and Disclosure Department of the
Exchange is satisfied that these items have been addressed, the Compliance
Review will not be concluded and the suspension of the Life Sciences Shares will
not be removed.


Forward Looking Statements

Except for statements of historical fact relating to the Corporation, certain
information contained herein constitutes forward-looking statements.
Forward-looking statements are based on the opinions and estimates of management
at the date the statements are made, and are subject to a variety of risks and
uncertainties and other factors that could cause actual events or results to
differ materially from those projected in the forward-looking statements. The
Corporation undertakes no obligation to update forward-looking statements if
circumstances or management's estimates or opinions should change. The reader is
cautioned not to place undue reliance on forward-looking statements.


The Change of Business

Completion of the transaction is subject to a number of conditions, including
Exchange acceptance and disinterested Shareholder approval. The transaction
cannot close until the required Shareholder approval is obtained. There can be
no assurance that the transaction will be completed as proposed or at all. 


Investors are cautioned that, except as disclosed in the Management Information
Circular to be prepared in connection with the transaction, any information
released or received with respect to the COB may not be accurate or complete and
should not be relied upon. Trading in the securities of Life Sciences Institutes
Inc. should be considered highly speculative. 


The TSX Venture Exchange has in no way passed upon the merits of the proposed
transaction and has neither approved nor disapproved the contents of this press
release.

Life Sciences Institute Inc. (TSXV:LSN)
Historical Stock Chart
Von Jun 2024 bis Jul 2024

Life Sciences Institute Inc. (TSXV:LSN)
Historical Stock Chart
Von Jul 2023 bis Jul 2024